PERRIGO ISRAEL FDA Approval ANDA 091553

ANDA 091553

PERRIGO ISRAEL

FDA Drug Application

Application #091553

Application Sponsors

ANDA 091553PERRIGO ISRAEL

Marketing Status

Prescription001

Application Products

001LOTION;TOPICAL0.05%0FLUTICASONE PROPIONATEFLUTICASONE PROPIONATE

FDA Submissions

ORIG1AP2013-07-30
LABELING; LabelingSUPPL4AP2019-11-27STANDARD
LABELING; LabelingSUPPL9AP2019-11-27STANDARD

Submissions Property Types

ORIG1Null7
SUPPL4Null7
SUPPL9Null7

TE Codes

001PrescriptionAB

CDER Filings

PERRIGO ISRAEL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91553
            [companyName] => PERRIGO ISRAEL
            [docInserts] => ["",""]
            [products] => [{"drugName":"FLUTICASONE PROPIONATE","activeIngredients":"FLUTICASONE PROPIONATE","strength":"0.05%","dosageForm":"LOTION;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"FLUTICASONE PROPIONATE","submission":"FLUTICASONE PROPIONATE","actionType":"0.05%","submissionClassification":"LOTION;TOPICAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.